Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 75.94K 70.68K 64.89K 123K 8.34M 124K 833K 327K 4.15M 328K 321K 13.92M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 214M 199M 183M 345M 23.46B 350M 2.34B 920M 11.68B 923M 903M 39.16B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.53%-3.95%+50.70%+152.78% 1,024B
+0.21%-2.68%+53.20%+50.87% 618B
-2.51%-3.25%+28.54%+67.99% 443B
+1.24%-0.56%+40.43%+34.14% 349B
+0.17%-1.07%+34.43%+42.76% 297B
-6.15%-8.41%+6.00%+8.29% 264B
-0.09%-5.94%-1.88%-42.78% 209B
-0.64%+2.43%+29.74%+67.16% 208B
-0.82%+0.70%+15.05%+72.05% 162B
Average -0.91%-1.21%+28.47%+50.36% 357.38B
Weighted average by Cap. -0.82%-2.17%+36.83%+73.20%

Financials

2016 2017
Net sales 54.27M 47.18M 43.91M 40.32M 76.13M 5.18B 77.31M 518M 203M 2.58B 204M 199M 8.65B 106M 92.1M 85.72M 78.71M 149M 10.11B 151M 1.01B 397M 5.04B 398M 389M 16.88B
Net income -103M -89.52M -83.32M -76.5M -144M -9.83B -147M -982M -385M -4.89B -387M -378M -16.41B -125M -109M -101M -93.01M -176M -11.95B -178M -1.19B -469M -5.95B -470M -460M -19.95B
Net Debt 209M 182M 170M 156M 294M 20B 298M 2B 784M 9.96B 787M 770M 33.38B 246M 214M 199M 182M 345M 23.45B 350M 2.34B 920M 11.67B 923M 902M 39.15B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock